Phase 2 Readout
SLS: Phase 2 Readout: sls009
December 31, 2026 · sls009. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- December 31, 2026
- Company
- SELLAS Life Sciences Group, Inc. (SLS)
- Drug
- sls009
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 2 Readout~quarter
Phase 2 Readout: sls009
- Drug
- sls009
- Indication
- newly diagnosed, high‑risk acute myeloid leukemia